Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mu Sun

Showing results (151-160 of 349) with videos related to

Pageof 35
Sort By:
European Journal of Immunology|January 28, 2021
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancerBo Mi Ku, Youjin Kim, Kyoung Young Lee, et al.
Stem Cell Research|January 12, 2013
Prevention of β-amyloid induced toxicity in human iPS cell-derived neurons by inhibition of Cyclin-dependent kinases and associated cell cycle eventsXiaohong Xu, Ying Lei, Jie Luo, et al.
Translational Cancer Research|July 11, 2024
Machine learning prediction of the case-fatality of COVID-19 and risk factors for adverse outcomes in patients with non-small cell lung cancerYe Ji Jung, Joonghyun Ahn, Sehhoon Park, et al.
Oral Oncology|June 29, 2011
Insulin-like growth factor binding protein-3, in association with IGF-1 receptor, can predict prognosis in squamous cell carcinoma of the head and neckJong-Mu Sun, Hyun Jung Jun, Young Hyeh Ko, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2013
Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factorsSu Jin Lee, Jung-Il Lee, Do-Hyun Nam, et al.
Journal of Translational Medicine|October 26, 2014
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinomaBo Mi Ku, Hyun Ae Jung, Jong-Mu Sun, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumorSeung Hwan Moon, Hae Su Kim, Young Seok Cho, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 21, 2015
A Prospective Phase II Study of Cisplatin and Cremophor EL-Free Paclitaxel (Genexol-PM) in Patients with Unresectable Thymic Epithelial TumorsHae Su Kim, Ji Yun Lee, Sung Hee Lim, et al.
Cancer Research and Treatment|March 18, 2017
Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with <i>EGFR</i>-Mutant Non-small Cell Lung CancerJong Ho Cho, Wei Zhou, Yoon-La Choi, et al.
Lung Cancer (Amsterdam, Netherlands)|December 5, 2009
Accuracy of RECIST 1.1 for non-small cell lung cancer treated with EGFR tyrosine kinase inhibitorsJong-Mu Sun, Myung-Ju Ahn, Min Jae Park, et al.
Pageof 35

Showing results (151-160 of 349) with videos related to

Sort By:
Pageof 35
European Journal of Immunology|January 28, 2021
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancerBo Mi Ku, Youjin Kim, Kyoung Young Lee, et al.
Stem Cell Research|January 12, 2013
Prevention of β-amyloid induced toxicity in human iPS cell-derived neurons by inhibition of Cyclin-dependent kinases and associated cell cycle eventsXiaohong Xu, Ying Lei, Jie Luo, et al.
Translational Cancer Research|July 11, 2024
Machine learning prediction of the case-fatality of COVID-19 and risk factors for adverse outcomes in patients with non-small cell lung cancerYe Ji Jung, Joonghyun Ahn, Sehhoon Park, et al.
Oral Oncology|June 29, 2011
Insulin-like growth factor binding protein-3, in association with IGF-1 receptor, can predict prognosis in squamous cell carcinoma of the head and neckJong-Mu Sun, Hyun Jung Jun, Young Hyeh Ko, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2013
Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factorsSu Jin Lee, Jung-Il Lee, Do-Hyun Nam, et al.
Journal of Translational Medicine|October 26, 2014
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinomaBo Mi Ku, Hyun Ae Jung, Jong-Mu Sun, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumorSeung Hwan Moon, Hae Su Kim, Young Seok Cho, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 21, 2015
A Prospective Phase II Study of Cisplatin and Cremophor EL-Free Paclitaxel (Genexol-PM) in Patients with Unresectable Thymic Epithelial TumorsHae Su Kim, Ji Yun Lee, Sung Hee Lim, et al.
Cancer Research and Treatment|March 18, 2017
Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with <i>EGFR</i>-Mutant Non-small Cell Lung CancerJong Ho Cho, Wei Zhou, Yoon-La Choi, et al.
Lung Cancer (Amsterdam, Netherlands)|December 5, 2009
Accuracy of RECIST 1.1 for non-small cell lung cancer treated with EGFR tyrosine kinase inhibitorsJong-Mu Sun, Myung-Ju Ahn, Min Jae Park, et al.
Pageof 35